Ping Leng
Impact in
- Bioengineering top 10%
- Analytical Chemistry and Sensors
-
- Cancer-related molecular mechanisms research
Papers in
-
- Protein Tyrosine Phosphatases 1
-
- Galectins and Cancer Biology 1
- Co-authors
- Zhan‐Qi Cao (5 shared papers)Zhi Wang (1 shared paper)Yujun Liu (1 shared paper)Xi Yan (1 shared paper)Longfei Song (1 shared paper)Ning Han (1 shared paper)Kunpeng Dou (1 shared paper)Rongrong Wang (1 shared paper)
In The Last Decade
Ping Leng
10 papers receiving 402 citations
Peers
Comparison fields: 5 of 77
- Bioengineering 46
- Cancer Research 72
- Pharmaceutical Science 28
- Virology 13
- Oncology 72
Countries citing papers authored by Ping Leng
This map shows the geographic impact of Ping Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Leng more than expected).
Fields of papers citing papers by Ping Leng
This network shows the impact of papers produced by Ping Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Leng. The network helps show where Ping Leng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ping Leng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 185 | |
| 2 | 2019 | 83 | |
| 3 | 2020 | 44 | |
| 4 | 2023 | 23 | |
| 5 | 2022 | 22 | |
| 6 | 2024 | 14 | |
| 7 | 2020 | 13 | |
| 8 | 2023 | 12 | |
| 9 | 2021 | 7 | |
| 10 | Sorafenib plus Capecitabine for Patients with Advanced Hepatocellular Carcinoma | 2008 | 4 |
| 11 | 2025 | 0 | |
| 12 | 2025 | 0 | |
| 13 | 2022 | 0 |
About Ping Leng
Ping Leng is a scholar working on Molecular Biology, Immunology, Genetics, Virology and Oncology, having authored 13 papers that have together received 407 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cancer Treatment and Pharmacology (1 paper), MicroRNA in disease regulation (1 paper), Pharmacovigilance and Adverse Drug Reactions (1 paper), Galectins and Cancer Biology (1 paper), Protein Tyrosine Phosphatases (1 paper), Mesenchymal stem cell research (1 paper) and Poxvirus research and outbreaks (1 paper). The work is most often cited by research in Bioengineering (46 citations), Cancer Research (72 citations), Pharmaceutical Science (28 citations), Virology (13 citations) and Oncology (72 citations). Ping Leng has collaborated with scholars based in China and Taiwan. Frequent co-authors include Zhan‐Qi Cao, Zhi Wang, Yujun Liu, Xi Yan, Longfei Song, Ning Han, Kunpeng Dou, Rongrong Wang, Fengyun Wang and Chao‐Cheng Kaun. Their work appears in journals such as Biomedicine & Pharmacotherapy, International Journal of Biological Macromolecules, Frontiers in Immunology, Journal of Molecular Histology and Laboratory Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.